Baird Financial Group
NVCR icon

Baird Financial Group’s NovoCure NVCR Stock Holding History

Baird Financial Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,872
Closed -$466K – 1773
2023
Q3 		$466K Buy
28,872
+21,112
+272% +$609K ﹤0.01% 1357
2023
Q2 		$322K Sell
7,760
-6,523
-46% -$405K ﹤0.01% 1480
2023
Q1 		$859K Sell
14,283
-1,778
-11% -$142K ﹤0.01% 1142
2022
Q4 		$1.18M Buy
16,061
+230
+1% +$17.3K ﹤0.01% 1024
2022
Q3 		$1.2M Buy
15,831
+85
+0.5% +$6.63K ﹤0.01% 991
2022
Q2 		$1.09M Buy
+15,746
New +$1.19M ﹤0.01% 1048
2021
Q2 		– Sell
-8,619
Closed -$1.14M – 1765
2021
Q1 		$1.14M Buy
8,619
+1,720
+25% +$272K ﹤0.01% 1081
2020
Q4 		$1.19M Sell
6,899
-888
-11% -$122K ﹤0.01% 949
2020
Q3 		$867K Buy
7,787
+3,471
+80% +$278K ﹤0.01% 985
2020
Q2 		$256K Buy
4,316
+425
+11% +$28K ﹤0.01% 1353
2020
Q1 		$262K Buy
3,891
+1,345
+53% +$106K ﹤0.01% 1245
2019
Q4 		$215K Sell
2,546
-827
-25% -$66.8K ﹤0.01% 1447
2019
Q3 		$252K Buy
+3,373
New +$270K ﹤0.01% 1366

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Baird Financial Group's NVCR Position: Q4 2023 in Review

Baird Financial Group sold out of NovoCure (NVCR) in Q4 2023, closing a stake of 28,872 shares — an estimated $466K sold.

Baird Financial Group first reported a position in NVCR in Q3 2019 and held it in 13 quarters. The position peaked at $1.2M in Q3 2022. 219 funds tracked by Wall St. Rank hold NVCR as of Q4 2023.

  • Baird Financial Group reported no remaining NovoCure position as of Q4 2023 after selling out during the quarter.
  • Baird Financial Group sold 28,872 NovoCure shares in Q4 2023, an estimated $466K.
  • Baird Financial Group first reported a position in NovoCure in Q3 2019 and held it in 13 quarters.
  • Baird Financial Group's NovoCure position peaked at $1.2M in Q3 2022.
  • 219 funds tracked by Wall St. Rank held NovoCure as of Q4 2023.

Based on Baird Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.